These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38650308)

  • 21. Myasthenia gravis experimentally induced with muscle-specific kinase.
    Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
    Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.
    Pevzner A; Schoser B; Peters K; Cosma NC; Karakatsani A; Schalke B; Melms A; Kröger S
    J Neurol; 2012 Mar; 259(3):427-35. PubMed ID: 21814823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MuSK not MNGIE: Atypical MuSK-antibody myasthenia presenting as a genetic disorder.
    Thebault S; Gibbs E; Bourque P; McKim D; Rakhra K; Breiner A; Frykman H; Warman-Chardon J
    Neuromuscul Disord; 2021 Dec; 31(12):1279-1281. PubMed ID: 34690051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
    Sanadze AG; Sidnev DV; Karganov MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of myasthenia by immunization against muscle-specific kinase.
    Shigemoto K; Kubo S; Maruyama N; Hato N; Yamada H; Jie C; Kobayashi N; Mominoki K; Abe Y; Ueda N; Matsuda S
    J Clin Invest; 2006 Apr; 116(4):1016-24. PubMed ID: 16557298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.
    Huijbers MG; Zhang W; Klooster R; Niks EH; Friese MB; Straasheijm KR; Thijssen PE; Vrolijk H; Plomp JJ; Vogels P; Losen M; Van der Maarel SM; Burden SJ; Verschuuren JJ
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20783-8. PubMed ID: 24297891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis.
    Vergoossen DLE; Plomp JJ; Gstöttner C; Fillié-Grijpma YE; Augustinus R; Verpalen R; Wuhrer M; Parren PWHI; Dominguez-Vega E; van der Maarel SM; Verschuuren JJ; Huijbers MG
    Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
    Koneczny I; Cossins J; Waters P; Beeson D; Vincent A
    PLoS One; 2013; 8(11):e80695. PubMed ID: 24244707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-fiber electromyography during menstrual exacerbation and ovulatory suppression in MuSK antibody-positive myasthenia gravis.
    Stickler DE; Stickler LL
    Muscle Nerve; 2007 Jun; 35(6):808-11. PubMed ID: 17221882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients.
    Li Y; Guptill JT; Russo MA; Massey JM; Juel VC; Hobson-Webb LD; Howard JF; Chopra M; Liu W; Yi JS
    Exp Neurol; 2019 Feb; 312():43-50. PubMed ID: 30472069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo.
    Benveniste O; Jacobson L; Farrugia ME; Clover L; Vincent A
    J Neuroimmunol; 2005 Dec; 170(1-2):41-8. PubMed ID: 16213598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients.
    Koneczny I; Stevens JA; De Rosa A; Huda S; Huijbers MG; Saxena A; Maestri M; Lazaridis K; Zisimopoulou P; Tzartos S; Verschuuren J; van der Maarel SM; van Damme P; De Baets MH; Molenaar PC; Vincent A; Ricciardi R; Martinez-Martinez P; Losen M
    J Autoimmun; 2017 Feb; 77():104-115. PubMed ID: 27965060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody.
    Morsch M; Reddel SW; Ghazanfari N; Toyka KV; Phillips WD
    J Physiol; 2013 May; 591(10):2747-62. PubMed ID: 23440963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.
    Rivner MH; Pasnoor M; Dimachkie MM; Barohn RJ; Mei L
    Neurol Clin; 2018 May; 36(2):293-310. PubMed ID: 29655451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology.
    Fichtner ML; Jiang R; Bourke A; Nowak RJ; O'Connor KC
    Front Immunol; 2020; 11():776. PubMed ID: 32547535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients.
    Takata K; Stathopoulos P; Cao M; Mané-Damas M; Fichtner ML; Benotti ES; Jacobson L; Waters P; Irani SR; Martinez-Martinez P; Beeson D; Losen M; Vincent A; Nowak RJ; O'Connor KC
    JCI Insight; 2019 Jun; 4(12):. PubMed ID: 31217355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nature and Action of Antibodies in Myasthenia Gravis.
    Ruff RL; Lisak RP
    Neurol Clin; 2018 May; 36(2):275-291. PubMed ID: 29655450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis.
    Xu K; Jha S; Hoch W; Dryer SE
    Neuroscience; 2006 Dec; 143(3):655-9. PubMed ID: 17081697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
    Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
    Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.